Pharmaceutical Vials Market Set to Hit USD 18.8 Billion by 2030

The Global Pharmaceutical Vials Market is experiencing accelerated growth driven by expanding production of biologics, vaccines, and sterile injectable medicines. According to Exactitude Consultancy, the market is expected to reach USD 18.8 billion by 2030, rising from USD 10.2 billion in 2023, representing a CAGR of 8.2% between 2024 and 2030.

This rise is supported by stronger regulatory focus on sterility, increasing global vaccination drives, expansion of fill-finish capacities, and the move from traditional packaging formats to high-quality molded and tubular glass vials.

Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/73460

Key Takeaways
• Market Value (2023): USD 10.2 billion
• Market Value (2030): USD 18.8 billion
• CAGR (2024-2030): 8.2%
• Primary Growth Drivers: Biologics, sterile injectables, vaccine production, and pharmaceutical expansion in Asia.
• Preferred Material: Borosilicate glass continues to dominate.
• Fastest-Growing End-Use: Biotech & biologics manufacturers.

Market Story
Pharmaceutical vials-essential for storing vaccines, injectable drugs, and lyophilized formulations-have become central to the global pharma packaging ecosystem. With biologics and biosimilars expanding rapidly, demand for high-quality, contamination-resistant vials has surged.
The COVID-19 pandemic permanently accelerated capacity building for fill-finish operations, leading to long-term investments in automated vial handling lines, depyrogenation tunnels, and inspection systems. Governments and pharmaceutical manufacturers are prioritizing robust vial supply chains to support emergency stockpiles and future pandemic preparedness.
Glass remains the material of choice, especially Type I borosilicate, due to its superior chemical resistance. However, polymer vials (COP & COC) are gaining attention for break-resistance and improved handling in sensitive biologic formulations.

Market Segments
By Material
• Glass (Borosilicate - Type I, Type II, Type III)
• Plastic (COP, COC, PP, PET, HDPE)
Glass vials dominate with over 80% share, but plastic vials are growing faster due to superior impact resistance.

By Product Type
• Tubular Vials
• Molded Vials
Tubular vials lead due to precision, dimensional accuracy, and suitability for high-speed fill-finish.

By Capacity
• 2 mL - 10 mL (Highest Demand)
• 10 mL - 50 mL
• Above 50 mL
The 2-10 mL range is the most widely used for vaccines, biologics, and lyophilized drugs.

By Application
• Vaccines
• Biologics & Biosimilars
• Chemotherapy & Oncology Injectables
• Lyophilized Drugs
• Diagnostic Reagents
• IV/Infusion Formulations
Biologics and oncology drugs are the fastest-growing segments, driving demand for high-purity sterile vials.

By End-User
• Pharmaceutical Companies
• Biotech Companies
• Contract Manufacturing Organizations (CMOs/CDMOs)
• Research Laboratories
• Healthcare Centers & Hospitals
CMOs/CDMOs are experiencing the highest growth due to increased outsourcing.

Explore Full Report here: https://exactitudeconsultancy.com/reports/73460/pharmaceutical-vials-market

Recent Industry Developments
• 2024 - Schott AG expanded its pharma glass capacity in India and Germany to support global biologics demand.
• 2024 - Gerresheimer announced investments in COP/COC plastic vial manufacturing for sensitive biologics.
• 2023 - Stevanato Group introduced enhanced Type I borosilicate vials integrated with anti-shatter technology.
• 2023 - Corning Inc. expanded Valor® Glass adoption to support vaccine stability and reduce vial breakage.
• 2023 - SGD Pharma upgraded sterile ready-to-use (RTU) vial production lines for injectable drugmakers.

Expert Quote
"The shift toward injectable biologics and personalized medicines is creating long-term, sustainable demand for high-quality pharmaceutical vials. Companies investing in scalable vial production and RTU formats will remain ahead in supply chain resilience and regulatory compliance."
- Irfan Tamboli, Business Development Executive, Exactitude Consultancy

Key Market Drivers
1. Growth of Biologics & Biosimilars
Biologics now account for a major share of global drug approvals, boosting demand for high-purity, sterile vials.
2. Vaccination Programs & Preparedness
Governments are stocking strategic vaccine reserves, driving large-volume vial procurement.
3. Sterile Packaging Regulations
Stringent guidelines by FDA, USP, EMA, and WHO increase the need for compliant borosilicate vials.
4. Expansion of Fill-Finish Capabilities
Automated lines boosting throughput and reducing contamination risks are increasing vial consumption.
5. Rise in Injectable & Oncology Therapies
Targeted therapies and immunotherapies rely heavily on vial packaging.

Forecast Outlook (2024-2030)
The market will continue expanding at a strong pace due to:
• Increased reliance on injectables
• Growing CDMO outsourcing
• Development of break-resistant glass
• Rising adoption of RTU sterile vials
By 2030, RTU (Ready-to-Use) vials and COP/COC plastic vials will show double-digit growth.

Regional Insights
North America
Largest share driven by biologics innovation, strong CDMO ecosystem, and vaccine manufacturing.
Europe
High demand from Germany, Switzerland, and Italy due to advanced sterile packaging lines.
Asia-Pacific
Fastest-growing region (CAGR > 10%) supported by large-scale pharmaceutical investments in India and China.
Latin America & Middle East
Increasing vial usage due to expansion of local injectable drug manufacturing.

Conclusion
The Pharmaceutical Vials Market is entering a period of sustained growth led by biologics, vaccines, and injectable therapies. With strong regulatory emphasis on sterility and the global expansion of fill-finish operations, vial manufacturers are poised for significant long-term demand.

This report is also available in the following languages : Japanese (医薬品バイアル市場), Korean (제약용 바이알 시장), Chinese (医药小瓶市场), French (Marché des flacons pharmaceutiques), German (Markt für pharmazeutische Ampullen), and Italian (Mercato delle fiale farmaceutiche), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/73460

Related Reports

cellulose Ether Market
https://exactitudeconsultancy.com/reports/76103/cellulose-ether-market

Precipitated Barium Sulphate Market
https://exactitudeconsultancy.com/reports/76110/precipitated-barium-sulphate-market

Chemical Intermediate Market
https://exactitudeconsultancy.com/reports/76111/chemical-intermediate-market

Ethylhexylglycerin Market
https://exactitudeconsultancy.com/reports/76143/ethylhexylglycerin-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.